|
Loctek Ergonomic Technology Corp. (300729.SZ) Avaliação DCF
CN | Industrials | Business Equipment & Supplies | SHZ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Loctek Ergonomic Technology Corp. (300729.SZ) Bundle
Aprimore suas estratégias de investimento com a calculadora DCF (300729SZ)! Mergulhe na autêntica Loctek Ergonomic Technology Corp. Financia, ajuste as previsões e despesas do crescimento e observe instantaneamente como essas mudanças afetam o valor intrínseco de (300729SZ).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 978.1 | 1,940.7 | 2,871.3 | 3,208.3 | 3,901.7 | 5,654.8 | 8,195.5 | 11,877.7 | 17,214.5 | 24,949.0 |
| Revenue Growth, % | 0 | 98.42 | 47.95 | 11.74 | 21.61 | 44.93 | 44.93 | 44.93 | 44.93 | 44.93 |
| EBITDA | 110.8 | 287.8 | 373.9 | 542.0 | 1,128.2 | 961.2 | 1,393.1 | 2,019.1 | 2,926.3 | 4,241.0 |
| EBITDA, % | 11.33 | 14.83 | 13.02 | 16.89 | 28.92 | 17 | 17 | 17 | 17 | 17 |
| Depreciation | 27.8 | 37.3 | 106.6 | 183.8 | 257.7 | 235.4 | 341.1 | 494.4 | 716.5 | 1,038.5 |
| Depreciation, % | 2.85 | 1.92 | 3.71 | 5.73 | 6.6 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 |
| EBIT | 83.0 | 250.5 | 267.4 | 358.2 | 870.5 | 725.9 | 1,052.0 | 1,524.7 | 2,209.7 | 3,202.6 |
| EBIT, % | 8.49 | 12.91 | 9.31 | 11.16 | 22.31 | 12.84 | 12.84 | 12.84 | 12.84 | 12.84 |
| Total Cash | 718.8 | 931.8 | 1,565.7 | 1,997.8 | 1,897.4 | 3,245.2 | 4,703.3 | 6,816.5 | 9,879.2 | 14,317.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 88.3 | 159.9 | 201.9 | 189.0 | 258.7 | 416.4 | 603.5 | 874.7 | 1,267.7 | 1,837.3 |
| Account Receivables, % | 9.03 | 8.24 | 7.03 | 5.89 | 6.63 | 7.36 | 7.36 | 7.36 | 7.36 | 7.36 |
| Inventories | 192.0 | 526.2 | 512.6 | 489.6 | 459.7 | 1,036.3 | 1,502.0 | 2,176.8 | 3,154.9 | 4,572.4 |
| Inventories, % | 19.63 | 27.11 | 17.85 | 15.26 | 11.78 | 18.33 | 18.33 | 18.33 | 18.33 | 18.33 |
| Accounts Payable | 155.9 | 476.0 | 525.4 | 341.7 | 466.3 | 920.2 | 1,333.6 | 1,932.8 | 2,801.2 | 4,059.8 |
| Accounts Payable, % | 15.94 | 24.53 | 18.3 | 10.65 | 11.95 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 |
| Capital Expenditure | -80.4 | -771.8 | -312.1 | -537.6 | -1,387.8 | -1,257.4 | -1,822.4 | -2,641.2 | -3,827.9 | -5,547.7 |
| Capital Expenditure, % | -8.22 | -39.77 | -10.87 | -16.76 | -35.57 | -22.24 | -22.24 | -22.24 | -22.24 | -22.24 |
| Tax Rate, % | 20.35 | 20.35 | 20.35 | 20.35 | 20.35 | 20.35 | 20.35 | 20.35 | 20.35 | 20.35 |
| EBITAT | 77.1 | 230.5 | 244.0 | 291.4 | 693.4 | 634.6 | 919.7 | 1,333.0 | 1,931.9 | 2,799.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -99.8 | -589.8 | 59.5 | -210.3 | -352.0 | -667.9 | -800.8 | -1,160.6 | -1,682.1 | -2,437.8 |
| WACC, % | 6.44 | 6.43 | 6.42 | 6.26 | 6.24 | 6.36 | 6.36 | 6.36 | 6.36 | 6.36 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -5,406.1 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | -2,523 | |||||||||
| Terminal Value | -88,267 | |||||||||
| Present Terminal Value | -64,854 | |||||||||
| Enterprise Value | -70,260 | |||||||||
| Net Debt | 868 | |||||||||
| Equity Value | -71,128 | |||||||||
| Diluted Shares Outstanding, MM | 312 | |||||||||
| Equity Value Per Share | -227.64 |
What You Will Receive
- Pre-Filled Financial Model: Loctek Ergonomic Technology's actual data enables accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates provide immediate results as you make adjustments.
- Investor-Ready Template: A polished Excel file crafted for professional-level valuation.
- Customizable and Reusable: Designed for adaptability, facilitating repeated use for in-depth forecasts.
Key Features
- 🔍 Real-Life LOCT Financials: Pre-filled historical and projected data for Loctek Ergonomic Technology Corp. (300729SZ).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Loctek’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Loctek’s valuation instantly after making adjustments.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Loctek Ergonomic Technology Corp. (300729SZ).
- Step 2: Examine the pre-filled financial data and forecasts for Loctek.
- Step 3: Adjust essential inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
- Step 5: Evaluate the results and utilize the findings for your investment decisions.
Why Opt for This Calculator?
- User-Friendly Design: Crafted for both novices and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your analysis needs.
- Real-Time Feedback: Observe immediate updates to Loctek Ergonomic Technology Corp.'s valuation as you tweak inputs.
- Preconfigured for Convenience: Comes with Loctek's actual financial data for fast analysis.
- Endorsed by Industry Experts: Utilized by investors and analysts for making knowledgeable choices.
Who Can Benefit from Loctek Ergonomic Technology Corp. (300729SZ)?
- Ergonomics Students: Explore design principles and analyze ergonomic solutions using real-world examples.
- Researchers: Utilize industry models in studies related to workplace ergonomics and health.
- Investors: Evaluate your investment strategies and assess market trends for Loctek Ergonomic Technology Corp. (300729SZ).
- Product Analysts: Enhance your analysis with a customizable model focused on ergonomic products.
- Office Managers: Learn how leading companies like Loctek optimize workspace comfort and productivity.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Loctek Ergonomic Technology Corp. (300729SZ), including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for the Weighted Average Cost of Capital (WACC), detailing parameters such as Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that reveal intrinsic value through comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to aid in analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios pertinent to Loctek Ergonomic Technology Corp. (300729SZ).
- Dashboard and Charts: A visual summary presenting valuation outputs and assumptions for straightforward analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.